This page traces its 1990 approval, the 2008 brand discontinuation, and how most patients access compounded sermorelin today, then covers the mechanism, safety notes, and the gene variants that shape the growth hormone axis it works through
Stack protocol: BPC-157: 250 to 500 mcg subcutaneous, once or twice a day Inject near the injury when you can reach it TB-500: 2 to 2.5 mg subcutaneous, twice a week (loading phase) Inject away from the injury, lower abdomen or outer thigh works fine 2 mg once a week (maintenance phase) Both run at the same time through the loading phase
What makes BPC-157 particularly notable as a research tool is the breadth of tissue types and biological systems in which it has demonstrated pre-clinical activity
Studies suggest that supplementing with betaine can significantly improve muscle endurance and enhance the quality of workouts [13]
However, as with any injectable therapy, certain risks and considerations must be understood and appropriately managed